trending Market Intelligence /marketintelligence/en/news-insights/trending/zpZAIKLyH0N0pSBn5RWSpA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Exactus to implement 1-for-8 reverse stock split to list on national exchange

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Exactus to implement 1-for-8 reverse stock split to list on national exchange

Exactus Inc. will implement a 1-for-8 reverse split of its common stock to position the company for a potential listing on a national exchange.

Common shares of the Glen Allen, Va.-based healthcare company, which produces hemp-derived cannabidiol, will start trading on a split-adjusted basis at market open on March 11. The company is listed on the OTCQB.

The company's stock will trade under the symbol EXDID for 20 trading days following the reverse split, after which the trading symbol will revert to EXDI.

Exactus' issued and outstanding shares will be reduced to about 25,575,482 shares after the reverse split from about 204,603,855 shares.

Exactus CEO Phil Young said, "Given our recent transition into a commercially focused hemp derived CBD company, we feel this split is occurring at the appropriate time as we transition into a revenue-generating company with a goal to list on a national exchange."